Key points from article :
BioXtek uses human birth tissues (placenta and umbilical cord) to create regenerative therapies.
Their goal is to regenerate tissues at the cellular level, treating diseases, not just symptoms.
It particularly focuses on amniotic fluid and Wharton’s jelly.
Their BioPUR process preserves the bioactive properties of these tissues.
BioXtek products are anti-inflammatory and anti-fibrotic, promoting healing and regeneration.
They manufacture various configurations of membrane patches to treat different wounds.
BioXtek’s future development includes biomimetic scaffolds, 3D printing, and gene editing.
They are also looking at controlled release systems and advanced hydrogels for better delivery.
